The Council of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) approved the appointment ...

Licensing deal with genXtraits and Mendel supports development of high-performance traits for challenging growing conditions In a move reflecting growing industry efforts to strengthen crop resilience ...

Frost & Sullivan's latest analysis, Growth Opportunities in Global Pharmaceutical Industry, 2026, finds that the pharmaceutical industry is entering a period of profound transformation as ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

AI‑assisted tools are rapidly transforming biotech innovation, enabling faster discovery and more sophisticated experimentation. At the same time, increased reliance on these tools raises complex and ...

An ASSOCHAM report projects India's pharma market to cross USD 120 billion by 2030, driven by global exports, AI drug discovery, biosimilars, and a shift from generics to core biotech innovation.

The state government has cleared four initiatives, including a startup accelerator in Mangaluru, an industry-academia ...

The US should be doing all it can to preserve its lead in pharmaceutical innovation against a resurgent China. Instead, it’s punishing a company whose main business is helping American firms discover, ...

Speaking in an exclusive interview with China Daily, soon after Bayer's China Innovation Day held at the company's Berlin ...

Gabay also spoke highly of China's drug regulatory reforms that encourage pharmaceutical innovation. "The average approval ...

By Manish Saini. The U.S. biotech sector is a high-growth, high-innovation industry and operates at the unique intersection ...